Prostate Cancer Whole Blood

<h2>Prostate Cancer Whole Blood for Research</h2>
Prostate cancer research relies heavily on PSA and emerging biomarkers like AR-V7 to guide diagnosis, risk stratification, and treatment selection. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed prostate cancer diagnosis for oncology biomarker research.
<h3>Product Features</h3>
<ul><li>Fresh whole blood from clinically diagnosed prostate cancer donors</li><li>Custom anticoagulants and collection tubes available</li><li>Same-day collection and shipment</li><li>Research Use Only (RUO)</li></ul>
<h3>De-identified Donor Data</h3>
<ul><li>Physician-confirmed diagnosis, including Gleason score and PSA levels where available</li><li>Demographics: age, sex assigned at birth, ethnicity</li><li>Relevant medical and treatment history</li></ul>
<h3>Applications</h3>
<ul><li>PSA and AR-V7 biomarker research</li><li>Circulating tumor cell and liquid-biopsy studies</li><li>Gene expression and transcriptomic analysis</li><li>Androgen deprivation therapy response research</li></ul>
<h3>Compliance and Quality</h3>
<ul><li>IRB-approved protocols and electronic informed consent</li><li>HIPAA-compliant donor data handling</li></ul>
<h3>Ordering and Customization</h3>
Prostate cancer whole blood is available in standard and custom volumes. Email <a href=”mailto:learnmore@sanguinebio.com”>learnmore@sanguinebio.com</a> for international orders or documentation requirements.